Table IV.
Eczema subgroup analyses: children (between two and 18 years)
| Risk level | Comparison | Number of participants (trials) |
Risk ratio (95% confidence interval) |
I2 (%) |
|---|---|---|---|---|
| High risk | Exclusive breastfeeding for at least six months versus introduction of solids at three to six months |
113 (1) | 0.97 (0.50, 1.89) | -- |
| Hydrolysed formula versus cow’s milk formula (prolonged feeding) |
950 (2) | 0.74 (0.40, 1.38) | 40 | |
| Extensively hydrolysed formula versus cow’s milk formula (prolonged feeding) |
651 (1) | 0.86 (0.63, 1.17) | -- | |
| Partially hydrolysed formula versus cow’s milk formula (prolonged feeding) |
510 (2) | 0.75 (0.37, 1.51) | 46 | |
| Extensively hydrolysed formula versus partially hydrolysed formula (prolonged feeding) |
661 (1) | 0.92 (0.67, 1.26) | -- | |
| Soy formula versus cow’s milk formula | 282 (2) | 1.51 (0.74, 3.10) | 18 | |
| Omega-3 fatty acid supplementation versus placebo |
516 (1) | 0.85 (0.62, 1.18) | -- | |
| Not selected for risk |
Hydrolysed formula versus h7uman milk (early short-term feeding) |
90 (1) | 0.48 (0.05, 4.41) | -- |
| Hyrdolysed formula versus cow’s milk formula (early short-term feeding) |
77 (1) | 0.34 (0.04, 3.15) | -- | |
| Omega-3 fatty acid supplementation versus placebo |
65 (1) | 1.24 (0.79, 1.95) | -- |